https://www.live-feeds.com/feed/pfizer-raises-2026-forecasts-as-eliquis-cancer-drugs-drive-third-quarter-resultsContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/pfizer-raises-2026-forecasts-as-eliquis-cancer-drugs-drive-third-quarter-resultshttps://www.live-feeds.com/feed/pfizer-raises-2026-forecasts-as-eliquis-cancer-drugs-drive-third-quarter-results#u181108Fri, 06 Nov 2026 11:56:33 +0000Pfizer raised its full-year profit and revenue forecasts on Tuesday, driven by higher-than-expected third-quarter results. Strong demand for the recently acquired cancer drug Padcev and the blockbuster blood thinner Eliquis propelled the financial beat. The pharmaceutical company also tapped a company veteran as its new chief financial officer. This performance reflects the momentum of Pfizer's post-COVID comeback as the company bets heavily on cancer and weight-loss drugs for its post-pandemic second act.Why it mattersThe upward revision of forecasts highlights Pfizer's strategic pi